{"id":11470,"date":"2025-09-29T11:57:08","date_gmt":"2025-09-29T11:57:08","guid":{"rendered":"https:\/\/polpharmabiologics.com\/?p=11470"},"modified":"2025-10-02T08:07:07","modified_gmt":"2025-10-02T08:07:07","slug":"polpharma-biologics-transformation","status":"publish","type":"post","link":"https:\/\/polpharmabiologics.com\/pl\/polpharma-biologics-transformation\/","title":{"rendered":"Polpharma Biologics is splitting its operations into two independent companies"},"content":{"rendered":"\n<p style=\"font-size:12px\"><em>Uprzejmie informujemy, \u017ce dokument jest dost\u0119pny wy\u0142\u0105cznie w wersji angloj\u0119zycznej.<\/em><\/p>\n\n\n\n<p><br><strong>Polpharma Biologics is splitting its operations into two independent companies, each with a clear focus and mission.<br><\/strong><br>We will operate our biosimilars business out of Switzerland, under the original brand \u2013 Polpharma Biologics. We remain dedicated to developing and commercializing our pipeline of high-quality biologic medicines. We chose Switzerland, a strong biotech hub, for its proximity to our business partners and for its top industry talent.<br><br>Our CDMO business has launched today under a new brand: Rezon Bio. We are building on our expertise and track record, to deliver cost-efficient solutions for biotech partners worldwide, from our state-of-the-art facilities in Poland, fully compliant with the highest international regulatory standards.<br><br>With sharpened focus and independence, both Polpharma Biologics and Rezon Bio are individually better positioned to compete globally and create value for partners and patients. This step is a continuation of our growth journey, rooted in the same strong foundations.<\/p>\n\n\n\n<figure class=\"wp-block-video\"><video height=\"2160\" style=\"aspect-ratio: 3840 \/ 2160;\" width=\"3840\" controls poster=\"https:\/\/polpharmabiologics.com\/wp-content\/uploads\/2025\/09\/rezon5.webp\" src=\"https:\/\/polpharmabiologics.com\/wp-content\/uploads\/2025\/09\/pb_spot.mp4\"><\/video><\/figure>\n\n\n\n<p><br>To stay up to date with the activities of both companies, follow their profiles on LinkedIn and visit the new Rezon Bio website:<br><br><a href=\"https:\/\/www.linkedin.com\/company\/polpharmabiologics\/\">LinkedIn Polpharma Biologics<\/a><br><br><a href=\"https:\/\/www.linkedin.com\/company\/rezonbio\/\">LinkedIn Rezon Bio<\/a><br><br><a href=\"http:\/\/www.rezonbio.com\">Rezon Bio Website<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Uprzejmie informujemy, \u017ce dokument jest dost\u0119pny wy\u0142\u0105cznie w wersji angloj\u0119zycznej. Polpharma Biologics is splitting its operations into two independent companies, each with a clear focus and mission.We will operate our biosimilars business out of Switzerland, under the original brand \u2013 Polpharma Biologics. We remain dedicated to developing and commercializing our pipeline of high-quality biologic medicines. [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":11494,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,1],"tags":[32],"class_list":["post-11470","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artykuly","category-bez-kategorii","tag-informacje-prasowe"],"_links":{"self":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts\/11470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/comments?post=11470"}],"version-history":[{"count":0,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts\/11470\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/media\/11494"}],"wp:attachment":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/media?parent=11470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/categories?post=11470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/tags?post=11470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}